• ChemFaces is a professional high-purity natural products manufacturer.
  • Product Intended Use
  • 1. Reference standards
  • 2. Pharmacological research
  • 3. Inhibitors
  • Home
  • Natural Products
  • Bioactive
  • Screening Libraries
  • Hot Products
  • Plant Catalog
  • Customer Support
  • Product Use Citation
  • About Us
  • Contact Us
  • Hot Products
    ChemFaces is a professional high-purity natural products manufacturer.

    The most popular products from ChemFaces – with maximum searches, inquiries and sales on ChemFaces.com. Get updates on latest trends. We're in a unique position to provide you with valuable information about which types of products people around the world are searching, and inquiring for each quarter.

    If you're looking for some popular natural product, check out our Popular Products display rack. These products are always in hot demand, so you can find natural products you like here.
    Natural Products
    Catalog No. Information
    CFN93712 3,5-di-O-caffeoylquinic acid

    3,5-di-O-caffeoylquinic acid as a neuraminidase inhibitory ligand in Flos Lonicerae, it has neuroprotective effects on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1. 3,5-di-O-caffeoylquinic acid also has antioxidant and anti-complementary activities.
    CFN90578 3,6'-Disinapoyl sucrose

    3,6'-Disinapoyl sucrose has neuroprotective effect and antidepressive activity in rats, at least in part, by increasing expression of cyclic AMP response element (CRE)-binding protein (CREB) and its downstream target protein, brain-derived neurotrophic factor (BDNF). 3,6'-Disinapoyl sucrose protect neuron cells from glutamate-induced excitotoxicity include the downregulation of proapoptotic gene Bax and the upregulation of antiapoptotic gene Bcl-2.
    CFN99025 3,8'-Biapigenin

    3, 8''-Biapigenin can modulate intracellular ROS production.
    CFN98217 3,8-Di-O-methylellagic acid

    3,3'-Di-O-methylellagic acid reveals moderate antibacterial activity, it also shows strong DPPH radical scavenging activities with SC50 of 123.3 ug/mL. It has a lower capacity of stimulating murine peritoneal macrophages to release nitric oxide and tumoural-alpha necrose factor. 3,3'-Di-O-methylellagic acid may be a useful as pharmacological agent for the treatment of neurodegenerative diseases.
    CFN97043 3,9-Dihydroxypterocarpan

    3,9-Dihydroxypterocarpan and phaseollidin are all good precursors of the pterocarpan phytoalexin phaseollin.
    CFN99067 3alpha-Akebonoic acid

    3α-Akebonoic acid shows interesting in vitro growth inhibitory activity against human tumor A549 and HeLa cell lines, it also shows significant in vitro α-glucosidase inhibitory activity. 3α-Akebonoic acid can interfer with presenilin-1 (PS1)/ β-site APP-cleaving enzyme 1 (BACE1) interaction and reduces Aβ production, the chemical interference of PS1/BACE1 interaction is a promising strategy for Alzheimer’s disease therapeutics.
    CFN90352 3alpha-Hydroxytanshinone IIA

    CFN92210 3-beta-O-(trans-p-Coumaroyl)maslinic acid

    1. 3-beta-O-(trans-p-Coumaroyl)maslinic acid is a DNA polymerase B" inhibitor.
    2. 3-beta-O-(trans-p-Coumaroyl)maslinic acid is a bleomycin cytotoxicity potentiator.
    CFN99588 3-Butylidenephthalide

    (Z)-3-butylidenephthalide has antihyperglycemic effect is due to inhibition of α-glucosidase at the intestinal level, inhibited the activity of yeast-α-glucosidase (IC(50) 2.35 mM) in a noncompetitive fashion with a K(i) of 4.86 mM. It can induce a dose-dependent antinociceptive action in the hot-plate assay, it is also effective for controlling the pain provoked by chemical irritation at the doses of 10 and 31.6 mg/kg.
    CFN92833 3-Deoxysappanchalcone

    3-Deoxysappanchalcone is an effective HO-1 inducer at the translational level. 3-Deoxysappanchalcone has anti-inflammatory, and anti-influenza virus activities, the mechanism involved anti-apoptosis and anti-inflammation activities in vitro. It has inhibitory activity on MMP-9 expression and production in TNF-α-treated cells, is mediated by the suppression of AP-1 and NF-κB activation.